Anika Therapeutics (ANIK) FCF Margin (QoQ) (2010 - 2026)
Anika Therapeutics (ANIK) FCF Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Anika Therapeutics | 285.40 Mn | 246.98 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,466.00 |
| Mar 31, 2026 | -3,423.00 |
| Dec 31, 2025 | -488.00 |
| Sep 30, 2025 | 2,378.00 |
| Jun 30, 2025 | 542.00 |
| Mar 31, 2025 | -1,219.00 |
| Dec 31, 2024 | -1,196.00 |
| Sep 30, 2024 | 2,741.00 |
| Jun 30, 2024 | -789.00 |
| Mar 31, 2024 | 5,536.00 |
| Dec 31, 2023 | -7,587.00 |
| Sep 30, 2023 | 3,586.00 |
| Jun 30, 2023 | -881.00 |
| Mar 31, 2023 | -8,669.00 |
| Dec 31, 2022 | 7,096.00 |
| Sep 30, 2022 | -37.00 |
| Jun 30, 2022 | 1,160.00 |
| Mar 31, 2022 | -1,805.00 |
| Dec 31, 2021 | 737.00 |
| Sep 30, 2021 | -362.00 |